Sartipy Fredrik, Garcia Pereira Filho Antonio José, Lundin Fredrik, Wahlberg Eric, Sigvant Birgitta
Section of Vascular Surgery, Department of Clinical Science and Education, Karolinska Institutet at Södersjukhuset, Kirurgkliniken, Sjukhusbacken 10, 118 83, Stockholm, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Int J Cardiol Cardiovasc Risk Prev. 2022 Apr 18;13:200130. doi: 10.1016/j.ijcrp.2022.200130. eCollection 2022 Jun.
This study evaluates the risks for adverse cardiovascular (CV) events in Asymptomatic Peripheral Arterial Disease (APAD) combined with different traditional CV risk factors.
A population-based observational study of 8000 subjects, identified 559 subjects as having APAD through ankle-brachial index (ABI) measurements and questionnaires regarding limb symptoms. This cohort and subgroups classified by presence of different traditional CV risk factors at baseline were assessed for 10 years on CV outcome. The recorded endpoints were all-cause mortality, CV mortality and non-fatal CV events.
Before subdividing the APAD subjects, the CV mortality incidence was 28.5 deaths per 1000 person-years as compared to 8.7 deaths for references without APAD. For subjects with hypertension at baseline the CV mortality incidence was 35.4 when combined with APAD and 11.7 without. In women with hypertension but without other risk factors, presence of APAD increased the age-adjusted Hazard Ratio (HR) for fatal and non-fatal CV events by 1.86 [CI 1.54,2.24, p < 0.001].
ABI measurements should be considered an important indication for aggressive multifactorial risk factor reduction in populations with any other prevalent CV risk factor. In hypertension, diabetes mellitus and a smoking history, coexisting APAD contributes significantly to the increased age-adjusted CV risk.
本研究评估无症状外周动脉疾病(APAD)合并不同传统心血管(CV)危险因素时发生心血管不良事件的风险。
一项基于人群的观察性研究,纳入8000名受试者,通过踝臂指数(ABI)测量和关于肢体症状的问卷,确定559名受试者患有APAD。对该队列以及根据基线时不同传统CV危险因素的存在情况进行分类的亚组,就心血管结局进行了10年的评估。记录的终点为全因死亡率、心血管死亡率和非致死性心血管事件。
在对APAD受试者进行细分之前,心血管死亡率发生率为每1000人年28.5例死亡,而无APAD的参照组为8.7例死亡。对于基线时有高血压的受试者,合并APAD时心血管死亡率发生率为35.4,无APAD时为11.7。在无其他危险因素的高血压女性中,APAD的存在使年龄调整后的致命和非致命心血管事件风险比(HR)增加了1.86[CI 1.54,2.24,p<0.001]。
对于有任何其他常见CV危险因素的人群,应将ABI测量视为积极进行多因素危险因素降低的重要指标。在高血压、糖尿病和吸烟史中,并存的APAD显著增加了年龄调整后的心血管风险。